Memento Medicines
PrivateLast Round
Series A
Jun 18, 2026
Total Funding Raised
$93M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Memento Medicines operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A round in June 2026.
Memento Medicines is a biotechnology company developing biologic therapies for retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Memento Medicines Comparables
Compare Memento Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MabTics Co., Ltd. | 88% | |
| INGENIA Therapeutics | 83% | |
| AffaMed Therapeutics | 81% |
For institutional investors. Book with your work email.
Memento Medicines Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Memento Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avego Management | Series A |
| RA Capital Management | Series A |
| Forbion | Series A |
| Sanofi Ventures | Series A |
| Samsara BioCapital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
$93M round led by RA Capital Management and Forbion.
For institutional investors. Book with your work email.
Memento Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Memento Medicines's valuation, stock price, and market status.
Is Memento Medicines a public or private company?
Memento Medicines is a private company.
What is the current stock price of Memento Medicines?
Memento Medicines is a private company, so its shares have no public market price. Caplight tracks Memento Medicines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Memento Medicines worth (valuation)?
Valuation information for Memento Medicines is not publicly available.
Can I buy Memento Medicines stock?
Memento Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Memento Medicines's last funding round?
Memento Medicines's most recent funding round was Series A on June 18, 2026.
Who are the main investors in Memento Medicines?
Key investors in Memento Medicines include Avego Management, RA Capital Management, Forbion.
Will Memento Medicines IPO soon?
No public IPO plans have been announced for Memento Medicines.
How can I track Memento Medicines secondary market activity?
Caplight tracks bids, offers, and trades in Memento Medicines's shares on secondary markets.